Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.65 |
| ▸ | PLAU | P00749 | 5/20 | 0.49 |
| ▸ | HPN | P05981 | 5/20 | 0.49 |
| ▸ | MMP2 | P08253 | 11/20 | 0.47 |
| ▸ | MMP9 | P14780 | 10/20 | 0.47 |
| ▸ | MMP8 | P22894 | 4/20 | 0.47 |
| ▸ | MMP12 | P39900 | 4/20 | 0.47 |
| ▸ | MMP14 | P50281 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 2/20 | 0.45 |
| ▸ | MMP13 | P45452 | 2/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1509766 | 0.94 | ITGB3 (0.71) | ITGB3ITGA2BPLAUHPNMMP2 | |
| SCHEMBL9293208 | 0.94 | ITGB3 (0.71) | ITGB3ITGA2BPLAUHPNMMP2 | |
| SCHEMBL1509767 | 0.94 | ITGB3 (0.71) | ITGB3ITGA2BPLAUHPNMMP2 | |
| Hydrochloric Acid SCHEMBL7362845 | 0.93 | ITGB3 (0.70) | ITGB3ITGA2BPLAUHPNMMP2 | |
| Ammonia Solution, Strong SCHEMBL8055739 | 0.93 | ITGB3 (0.70) | ITGB3ITGA2BPLAUHPNMMP2 | |
| Hydrochloric Acid SCHEMBL7362847 | 0.93 | ITGB3 (0.70) | ITGB3ITGA2BPLAUHPNMMP2 | |
| Methoxymethane SCHEMBL8925022 | 0.91 | ITGB3 (0.67) | ITGB3ITGA2BPLAUHPNMMP2 | |
| SCHEMBL1244355 | 0.87 | ITGB3 (0.60) | ITGB3ITGA2BPLAUHPNMMP2 | |
| Hydrochloric Acid SCHEMBL7319933 | 0.85 | ITGB3 (0.59) | ITGB3ITGA2BPLAUHPNMMP2 | |
| SCHEMBL77677 | 0.84 | MMP9 (0.67) | ITGB3ITGA2BPLAUHPNMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | ITGB3 2975/4885ITGA2B 2701/4885PLAU 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.